Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CPT2 |
| Upstream (Parents) |
|---|
| (<<) SLC27A2 → CPT2 |
| (<<) ETFDH → CPT2 |
| (<<) DHODH → CPT2 |
| Downstream (Children) |
|---|
| CPT2 → HIBCH (>>) |
| CPT2 → FDX1 (>>) |
| CPT2 → THNSL1 (>>) |
| CPT2 → ABHD3 (>>) |
| CPT2 → PADI3 (>>) |
| CPT2 → GCAT (>>) |
| CPT2 → PCNXL2 (>>) |
| CPT2 → PEX11A (>>) |
| CPT2 → MGC3771 (>>) |
| CPT2 → SYNGR4 (>>) |
| CPT2 → INSR (>>) |
| CPT2 → BEX1 (>>) |
| CPT2 → SURF1 (>>) |
| CPT2 → SEL1L (>>) |
| CPT2 → HIST1H1C (>>) |
| CPT2 → DNAJB9 (>>) |
| CPT2 → LACTB2 (>>) |
